Daniela et al. also found CD44 was indispensable for BCR-ABL-expressing leukemic stem cell to initiate CML and CD44 blockade decreased engraftment and impaired induction of CML-like myeloproliferative disease [9]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.